FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013673363> ?p ?o ?g. }

• W2013673363 endingPage "508" @default.
• W2013673363 startingPage "503" @default.
• W2013673363 abstract "Elderly women constitute a large group of breast cancer patients, and after multidimensional geriatric assessment (MGA) only a minor part of them are found in perfect health (=fit), while the remaining display one or more physical or functional limitations or familial/social problems and are therefore categorized as vulnerable or frail (=unfit). Although randomized trials have not produced modest evidence that surgery impacts on ultimate survival of elderly women with hormone-responsive tumors, there is a general consensus that age alone should not prevent surgical local treatment even in unfit women due to the limited morbidity of breast surgery and to the risk of local progression. Activity and safety of AIs appear comparable in elderly women compared to younger counterparts, although concomitant cardiovascular comorbidity and osteoporosis should be closely monitored. Of note, compliance to oral therapy in unfit women and possible interferences with concomitant medications are still poorly documented issues. With the exception of high-risk node positive and estrogen-receptor negative patients, administration of adjuvant chemotherapy for estrogen-receptor positive unfit patients is rarely recommended since the uncertain gain in relapse-free survival is exceeded by the increased risk of toxicity and competitive causes of death. Endocrine-responsive metastatic disease is managed with one or more lines of endocrine treatment as in younger patients. Single agent sequential chemotherapy regimens are to be preferred to combination regimens, which are usually more toxic with a limited survival gain even in younger patients. When and how dose reductions should be applied to unfit patients is highly controversial. Trastuzumab in association with chemotherapy can be administered to elderly patients presenting HER2 overexpressing tumors, although the risk of cardiac adverse events in unfit patients is largely unknown. Bevacizumab-based combinations increase the activity and also toxicity of taxane chemotherapy, and are not a preferred option." @default.
• W2013673363 created "2016-06-24" @default.
• W2013673363 creator A5015952023 @default.
• W2013673363 creator A5033285318 @default.
• W2013673363 creator A5079552127 @default.
• W2013673363 creator A5082704939 @default.
• W2013673363 date "2009-10-01" @default.
• W2013673363 modified "2023-10-14" @default.
• W2013673363 title "Management of primary and advanced breast cancer in older unfit patients (medical treatment)" @default.
• W2013673363 cites W1529243395 @default.
• W2013673363 cites W1759175391 @default.
• W2013673363 cites W1988303925 @default.
• W2013673363 cites W1991981105 @default.
• W2013673363 cites W2003564950 @default.
• W2013673363 cites W2022917890 @default.
• W2013673363 cites W2023550522 @default.
• W2013673363 cites W2031096462 @default.
• W2013673363 cites W2042215902 @default.
• W2013673363 cites W2043103956 @default.
• W2013673363 cites W2045324973 @default.
• W2013673363 cites W2047197800 @default.
• W2013673363 cites W2047246104 @default.
• W2013673363 cites W2048508323 @default.
• W2013673363 cites W2049566046 @default.
• W2013673363 cites W2050847264 @default.
• W2013673363 cites W2060956500 @default.
• W2013673363 cites W2065283592 @default.
• W2013673363 cites W2071559885 @default.
• W2013673363 cites W2072839579 @default.
• W2013673363 cites W2085053154 @default.
• W2013673363 cites W2099199992 @default.
• W2013673363 cites W2100014422 @default.
• W2013673363 cites W2101580858 @default.
• W2013673363 cites W2102620699 @default.
• W2013673363 cites W2103918649 @default.
• W2013673363 cites W2104316189 @default.
• W2013673363 cites W2104775804 @default.
• W2013673363 cites W2110190287 @default.
• W2013673363 cites W2121785313 @default.
• W2013673363 cites W2122911205 @default.
• W2013673363 cites W2123721927 @default.
• W2013673363 cites W2129816567 @default.
• W2013673363 cites W2130521606 @default.
• W2013673363 cites W2133667885 @default.
• W2013673363 cites W2134350728 @default.
• W2013673363 cites W2134356947 @default.
• W2013673363 cites W2139524087 @default.
• W2013673363 cites W2141751399 @default.
• W2013673363 cites W2145040712 @default.
• W2013673363 cites W2145545573 @default.
• W2013673363 cites W2152409486 @default.
• W2013673363 cites W2163940216 @default.
• W2013673363 cites W2165782026 @default.
• W2013673363 cites W2167238270 @default.
• W2013673363 cites W2167527499 @default.
• W2013673363 cites W2167766783 @default.
• W2013673363 cites W2167849036 @default.
• W2013673363 cites W2169203358 @default.
• W2013673363 cites W2279875322 @default.
• W2013673363 cites W291054678 @default.
• W2013673363 doi "https://doi.org/10.1016/j.ctrv.2009.04.002" @default.
• W2013673363 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19762156" @default.
• W2013673363 hasPublicationYear "2009" @default.
• W2013673363 type Work @default.
• W2013673363 sameAs 2013673363 @default.
• W2013673363 citedByCount "41" @default.
• W2013673363 countsByYear W20136733632012 @default.
• W2013673363 countsByYear W20136733632013 @default.
• W2013673363 countsByYear W20136733632014 @default.
• W2013673363 countsByYear W20136733632015 @default.
• W2013673363 countsByYear W20136733632016 @default.
• W2013673363 countsByYear W20136733632017 @default.
• W2013673363 countsByYear W20136733632018 @default.
• W2013673363 countsByYear W20136733632020 @default.
• W2013673363 countsByYear W20136733632022 @default.
• W2013673363 crossrefType "journal-article" @default.
• W2013673363 hasAuthorship W2013673363A5015952023 @default.
• W2013673363 hasAuthorship W2013673363A5033285318 @default.
• W2013673363 hasAuthorship W2013673363A5079552127 @default.
• W2013673363 hasAuthorship W2013673363A5082704939 @default.
• W2013673363 hasConcept C121608353 @default.
• W2013673363 hasConcept C126322002 @default.
• W2013673363 hasConcept C141071460 @default.
• W2013673363 hasConcept C143998085 @default.
• W2013673363 hasConcept C168563851 @default.
• W2013673363 hasConcept C2776694085 @default.
• W2013673363 hasConcept C2777176818 @default.
• W2013673363 hasConcept C2779134260 @default.
• W2013673363 hasConcept C2779384505 @default.
• W2013673363 hasConcept C2779786085 @default.
• W2013673363 hasConcept C530470458 @default.
• W2013673363 hasConcept C71924100 @default.
• W2013673363 hasConceptScore W2013673363C121608353 @default.
• W2013673363 hasConceptScore W2013673363C126322002 @default.
• W2013673363 hasConceptScore W2013673363C141071460 @default.
• W2013673363 hasConceptScore W2013673363C143998085 @default.
• W2013673363 hasConceptScore W2013673363C168563851 @default.
• W2013673363 hasConceptScore W2013673363C2776694085 @default.

• next